Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 6:8:655598.
doi: 10.3389/fcvm.2021.655598. eCollection 2021.

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy

Affiliations
Review

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy

Yaoyao Guo et al. Front Cardiovasc Med. .

Abstract

In recent years, diabetes mellitus has become a global issue with increasing incidence rate worldwide. Diabetic cardiomyopathy (DCM), one of the important complications of diabetes, refers to patients with type 1 and type 2 diabetes who have ventricular hypertrophy, fibrosis and even diastolic dysfunction. The pathogenesis of DCM is related to oxidative stress, inflammatory response, apoptosis, autophagy, myocardial fibrosis and, diabetic microangiopathy. Long non-coding RNAs (lncRNA) is a non-coding RNA with a length longer than 200 nucleotides which lack the ability of protein coding. With the development of molecular technology, massive evidence demonstrates that lncRNA play a critical role in the molecular mechanism of DCM. Moreover, it can also be used as potential diagnostic markers for DCM. In this review, we intend to summarize the pathological roles and molecular mechanism of lncRNA in the progression of diabetic cardiomyopathy, which may provide promising diagnosis and treatment strategies for DCM.

Keywords: diabetes mellilus; diabetic cardiomyopathy; fibrosis; hypertrophy; long non-coding RNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Pathogenesis of diabetic cardiomyopathy. In diabetes mellitus, insulin resistance, hyperglycemia and hyperinsulinemia can cause cardiac insulin resistance and metabolic disorders that induce microvascular dysfunction, Oxidative stress, inflammation, autonomic neuropathy, AGEs, endoplasmic, activated RAAS, mitochondria dysfunction, as well as impaired Ca2+ handling. These pathophysiological abnormalities together lead to cardiac fibrosis and hypertrophy, cardiomyocyte death, and dysfunction of coronary microcirculation. Finally, these pathogenic changes in the myocardium impair the diastolic and systolic function of the heart and result in heart failure.
Figure 2
Figure 2
The major function of LncRNAs. (A) LncRNA acts as protein scaffolds and regulates protein function. (B) LncRNA acts as competitive endogenous RNA to interact with miRNAs. (C) LncRNA serves host genes to promote the generation of miRNA. (D) LncRNA serves as a guide to promote the transcriptional regulation via tethering transcription factors (TF) to the promoter region. (E) LncRNA serves as decoys to inhibit gene expression via interacting with TF.

References

    1. Abdulle LE, Hao JL, Pant OP, Liu XF, Zhou DD, Gao Y, et al. . MALAT1 as a Diagnostic and therapeutic target in diabetes-related complications : a promising. Int J Med Sci. (2019) 16:548–55. 10.7150/ijms.30097 - DOI - PMC - PubMed
    1. Tao H, Ding XS, Yang JJ, Shi KH, Li J. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fi brosis : new advances and perspectives. Endocrine. (2018) 62:281–91. 10.1007/s12020-018-1688-z - DOI - PubMed
    1. Zhang W, Xu W, Feng Y, Zhou X. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy. J Cell Mol Med. (2019) 23:5859–67. 10.1111/jcmm.14510 - DOI - PMC - PubMed
    1. Pant T, Dhanasekaran A, Fang J, Bai X, Bosnjak ZJ, Liang M, et al. . Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord. (2018) 18:197. 10.1186/s12872-018-0939-5 - DOI - PMC - PubMed
    1. Yang F, Qin Y, Lv J, Wang YQ, Che H, Jiang YN, et al. . Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. (2018) 9:1000. 10.1038/s41419-018-1029-4 - DOI - PMC - PubMed

LinkOut - more resources